| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/19/2009 | US20090048583 Intravascular delivery system for therapeutic agents |
| 02/19/2009 | US20090048349 Compositions and kits for compounding pharmaceuticals |
| 02/19/2009 | US20090048344 Pharmaceutical composition comprising 5-methyl-2-2' (chloro-6'-fluoroanilino phe nylacetic acid |
| 02/19/2009 | US20090048341 Oral administering; controlling blood concentration; sustained release; urogenital disorders; blood disorders |
| 02/19/2009 | US20090048331 Methods and formulations for the delivery of pharmacologically active agents |
| 02/19/2009 | US20090048206 Edible powder meterial having excellent shelf stability |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048180 Sustained-release preparation |
| 02/19/2009 | US20090047366 Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants |
| 02/19/2009 | US20090047358 Phospholipid-based powders for drug delivery |
| 02/19/2009 | US20090047357 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 02/19/2009 | US20090047356 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports; antitumor agents; kits |
| 02/19/2009 | US20090047355 Process for producing pulverulent phytosterol formulations |
| 02/19/2009 | US20090047354 process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate |
| 02/19/2009 | US20090047353 Changing th1/th2 balance in split influenza vaccines with adjuvants |
| 02/19/2009 | US20090047351 Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom |
| 02/19/2009 | US20090047350 Perforated water soluble polymer based edible films |
| 02/19/2009 | US20090047349 Drug delivery device |
| 02/19/2009 | US20090047348 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 02/19/2009 | US20090047347 Compositions for Drug Administration |
| 02/19/2009 | US20090047346 Sustained release formulations of sotalol |
| 02/19/2009 | US20090047345 Sustained-release tramadol formulations with 24-hour efficacy |
| 02/19/2009 | US20090047344 Formulations |
| 02/19/2009 | US20090047343 Method for stabilizing phenylephrine |
| 02/19/2009 | US20090047342 Methods of Treating Infectious Diseases |
| 02/19/2009 | US20090047341 Capsules of core/shell type and preparation process |
| 02/19/2009 | US20090047340 Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047338 Method to Treat Flavivirus Infection with siRNA |
| 02/19/2009 | US20090047337 Method of administering a cationic liposomal preparation |
| 02/19/2009 | US20090047336 novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| 02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
| 02/19/2009 | US20090047334 Transdermal patch for extended delivery of calcium |
| 02/19/2009 | US20090047333 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 02/19/2009 | US20090047331 Sustained release film formulation for healing wound comprising epidermal growth factor |
| 02/19/2009 | US20090047330 Oral fast dissolving films for erectile dysfunction bioactive agents |
| 02/19/2009 | US20090047329 Mesocellular oxide foams as hemostatic compositions and methods of use |
| 02/19/2009 | US20090047328 Caffeine delivery systems |
| 02/19/2009 | US20090047327 Sinus delivery of sustained release therapeutics |
| 02/19/2009 | US20090047326 Sinus delivery of sustained release therapeutics |
| 02/19/2009 | US20090047324 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047321 Antimicrobial compounds having protective or therapeutic leaving groups |
| 02/19/2009 | US20090047320 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions |
| 02/19/2009 | US20090047318 Nanoparticle-coated medical devices and formulations for treating vascular disease |
| 02/19/2009 | US20090047316 Porous particles loaded with cosmetically or pharmaceutically active compounds |
| 02/19/2009 | US20090047315 Porous magnesia and process for preparing the same |
| 02/19/2009 | US20090047314 Microencapsulation systems and applications of same |
| 02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
| 02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
| 02/19/2009 | US20090047209 Novel nifedipine compositions |
| 02/19/2009 | DE102007037099A1 Verfahren und Vorrichtung zum Konstanthalten eines pH-Wertes einer medizinischen Flüssigkeit beim Ablassen aus einem Behälter Method and device for maintaining a constant pH of a medical liquid when draining from a container |
| 02/19/2009 | CA2733676A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | CA2696341A1 Abuse resistant drugs, method of use and method of making |
| 02/19/2009 | CA2696338A1 Gelatin-based coatings having improved durability |
| 02/19/2009 | CA2696063A1 Immediate release and sustained release ibuprofen dosing form |
| 02/19/2009 | CA2695990A1 Saline nose wipe and methods of manufacture and use |
| 02/19/2009 | CA2695892A1 Non-aggregating virus formulation |
| 02/19/2009 | CA2695759A1 Method for stabilizing phenylephrine |
| 02/19/2009 | CA2694973A1 Toll like receptor modulators |
| 02/19/2009 | CA2694836A1 Solid valsartan composition |
| 02/19/2009 | CA2694625A1 Dye-loaded particles |
| 02/19/2009 | CA2680680A1 Modified dosage forms of tacrolimus |
| 02/18/2009 | EP2025720A1 Spray-drying process for the manufacture of dye-loaded particles |
| 02/18/2009 | EP2025353A2 Injectable polysaccharide-cell compositions |
| 02/18/2009 | EP2025339A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF |
| 02/18/2009 | EP2025334A1 Sustained release drug delivery system for repeated administration |
| 02/18/2009 | EP2025333A1 Injectable pharmaceutical formulation of taxoids |
| 02/18/2009 | EP2025332A1 Clay-based aromatised therapeutic composition |
| 02/18/2009 | EP2024999A1 Device and method for the controlled release of a predefined quantity of a substance |
| 02/18/2009 | EP2023958A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023957A2 Oral liquid loratadine formulations and methods |
| 02/18/2009 | EP2023949A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| 02/18/2009 | EP2023928A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023908A1 Multi-layer medical patch with impermeable center |
| 02/18/2009 | EP2023907A1 Transdermal delivery system comprising sufentanil and its analogues |
| 02/18/2009 | EP2023906A2 Delayed-release compositions of extended release forms of venlafaxine |
| 02/18/2009 | EP2023905A2 Passive time released solute treatment |
| 02/18/2009 | EP2023904A2 Sustained release coated tablet with precisely regulated release profile |
| 02/18/2009 | EP2023903A1 Process for the preparation and surface coating of pellets |
| 02/18/2009 | EP2023902A1 Dpp iv inhibitor formulations |
| 02/18/2009 | EP2023901A1 Pharmaceutical composition comprising tetrahydrolipstatin |
| 02/18/2009 | EP2023900A1 Controlled dose drug delivery system |
| 02/18/2009 | EP2023899A1 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 02/18/2009 | EP2023898A1 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 02/18/2009 | EP2023897A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 02/18/2009 | EP2023896A2 A composition for inactivating an enveloped virus |
| 02/18/2009 | EP2023895A2 Pharmaceutical compositions for vein irritating drugs |
| 02/18/2009 | EP2023894A2 Fixed combination dosage forms for the treatment of migraine |
| 02/18/2009 | EP2023893A2 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 02/18/2009 | EP2023810A2 Medical electrode containing a hydrophilic polymer |
| 02/18/2009 | EP2023801A2 System for monitoring of patients |
| 02/18/2009 | EP1904297A4 Compositions comprising elemental metals and uses therefor |
| 02/18/2009 | EP1773253A4 Spinal disc nucleus pulposus implant |
| 02/18/2009 | EP1699465B1 The use of hydrocortisone to treat depression |
| 02/18/2009 | EP1663243B1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer |
| 02/18/2009 | EP1663171B1 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 02/18/2009 | EP1636260B1 Improved secretion of neublastin |
| 02/18/2009 | EP1562630A4 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 02/18/2009 | EP1534249A4 Chewable soft capsule |
| 02/18/2009 | EP1513493B1 Analgesics |